Support therapeutic antibody discovery and optimization with Fv/CDR structure modeling, antibody-antigen docking, epitope/paratope analysis, humanization strategy, affinity maturation design, developability assessment and candidate prioritization.
Use Fv/CDR modeling, interface analysis and sequence review to prioritize candidates before experimental validation.
Use antibody-antigen docking, epitope/paratope interpretation and CDR optimization logic to guide affinity maturation design.
Identify aggregation, immunogenicity, stability, sequence-liability and manufacturability risks before candidate selection.
Model antibody variable regions, framework orientation and CDR loops to support structure-guided engineering decisions.
Generate plausible complex models, analyze epitope/paratope residues and identify interface regions for validation.
Support framework selection, CDR grafting review and back-mutation prioritization for therapeutic antibody development.
Prioritize CDR or interface variants to improve binding while managing specificity and structural risk.
Screen sequence and structure liabilities related to aggregation, stability, immunogenicity and manufacturability.
Support nanobody/VHH modeling, bispecific orientation or linker feasibility and ADC-related antibody assessment.
Used for Fv modeling, CDR identification, framework review and sequence-level liability assessment.
Structural model with CDR loop interpretation, framework orientation review and engineering-relevant annotations.
Used for antibody-antigen docking, epitope/paratope analysis and interface residue interpretation.
Complex model with key contact residues, interaction hotspots and validation-ready interface hypotheses.
Used to connect modeling results with experimental observations and focus candidate optimization priorities.
Prioritized antibody variants with structure-based rationale for affinity maturation or candidate selection.
Used for humanization strategy, format-specific modeling and developability risk evaluation.
Actionable report covering humanization considerations, sequence liabilities, aggregation risks and next-step recommendations.
Review antibody sequences, antigen information, binding data, antibody format and engineering objective.
Annotate CDRs, frameworks, liability motifs and format-specific structural considerations.
Build antibody models, perform docking when antigen data is available and interpret epitope/paratope residues.
Prioritize humanized, affinity-improved or liability-reduced variants based on the project objective.
Deliver models, variant recommendations, risk assessment and next-step experimental validation guidance.
Input: VH/VL sequences, known binding data and target antigen.
Output: Humanized variant panel, structural risk review and recommended back mutations.
Input: Lead antibody sequence, antigen information and assay notes.
Output: Prioritized CDR mutation set and experimental validation plan.
Input: Antibody and antigen sequences or structures.
Output: Complex models, epitope/paratope residue table and interface hotspot interpretation.
Useful inputs include heavy and light chain sequences, antibody format, antigen sequence or structure, known binding data, species origin, CDR or framework information, desired engineering objective and current project stage.
Yes. Structural modeling, CDR loop analysis, antibody-antigen docking, epitope/paratope interpretation and sequence liability assessment can support humanization strategy, affinity maturation design and candidate prioritization.
Yes. If antigen sequence or structure information is available, antibody-antigen docking can be included to generate complex models and analyze interface residues, interaction hotspots and epitope/paratope features.
Yes. Candidate ranking can integrate structural confidence, interface features, sequence liabilities, developability risks and project-specific criteria such as humanization, affinity improvement or stability optimization.
This is an expert-led antibody modeling and engineering service. Deliverables can include structural models, docking interpretation, candidate ranking, engineering recommendations and a technical report for downstream decision-making.
Submit your project details below, and our team will respond within 24 hours.
Talk to our technical team about your project!
I Want To Talk